Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZVRA Zevra Therapeutics

休市中 10-18 16:00:00 EDT

8.49

-0.04

-0.47%

盘后8.49

+0.000.00%

18:05 EDT

最高8.69	最低8.38	成交量38.34万
今开8.51	昨收8.53	日振幅3.63%
总市值4.47亿	流通市值4.19亿	总股本5,262万
成交额325.50万	换手率0.78%	流通股本4,929万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZVRA","market":"US","secType":"STK","nameCN":"Zevra Therapeutics","latestPrice":8.49,"timestamp":1729281600000,"preClose":8.53,"halted":0,"volume":383386,"hourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"18:05 EDT","volume":3653,"amount":31006.04,"timestamp":1729289133447},"delay":0,"floatShares":49294659,"shares":52617789,"eps":-1.700683,"marketStatus":"休市中","marketStatusCode":7,"change":-0.04,"latestTime":"10-18 16:00:00 EDT","open":8.51,"high":8.69,"low":8.38,"amount":3255012.3156200005,"amplitude":0.036342,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.700683,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1729497600000},"adr":0,"listingDate":1429156800000,"adjPreClose":8.53,"preHourTrading":{"tag":"盘前","latestPrice":8.2825,"preClose":8.53,"latestTime":"08:44 EDT","volume":200,"amount":1656.5000000000002,"timestamp":1729255490603},"postHourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"18:05 EDT","volume":3653,"amount":31006.04,"timestamp":1729289133447},"volumeRatio":0.66043030484365,"impliedVol":0.8015,"impliedVolPercentile":0.3611},"requestUrl":"/m/hq/s/ZVRA","defaultTab":"news","newsList":[{"id":"2473258105","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473258105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473258105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308262,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2470110086","title":"Zevra Therapeutics, Inc.盘中异动 股价大跌6.84%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470110086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470110086?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:37","pubTimestamp":1727444237,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速下跌6.84%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA","BK4139","BK4007"],"gpt_icon":0},{"id":"2469493565","title":"美国研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469493565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469493565?lang=zh_cn&edition=full","pubTime":"2024-09-24 20:39","pubTimestamp":1727181557,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 华尔街证券分析师周二修改了对几家美国上市公司的评级和目标价，其中包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将其目标价从 880 美元上调至 980 美元             * First Citizens Bancshares   ：Wedbush将其评级从 \"跑赢大盘 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7f827d8c01bff99b769de6f50473596e","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4105","LU1548497426.USD","TW","MCK","ZVRA","LW","PBH","LU1923622614.USD","BFH","SN","KVUE","LU0417517546.SGD","CL","LU2125909593.SGD","LU2360032135.SGD","BRZE","IDYA","LU1430594728.SGD","BK4106","BDTX","OKTA","SG9999014542.SGD","LU1974910355.USD","LU2125909916.SGD","LU2125909759.SGD","SBUX","SG9999001440.SGD","BHVN","DAY","IE00B7SZLL34.SGD","IE00BLSP4452.SGD","LU2087625088.SGD","PG","LU2106854487.HKD","EQIX","BK4222","LU1923622291.USD","REGN","PCOR","IE00BZ1G4Q59.USD","CHD","LU2237438978.USD","LU1720051108.HKD","COST","SHAK","BK4155"],"gpt_icon":1},{"id":"2469083437","title":"欧洲研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469083437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469083437?lang=zh_cn&edition=full","pubTime":"2024-09-24 15:11","pubTimestamp":1727161860,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 周二，证券分析师修改了对多家欧洲公司的评级和目标价，包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将目标价从880美元上调至980美元 * McKesson Corp   ：贝尔德将目标价从603美元下调至531美元 * 星巴克  ：杰富瑞将其评级从 \"持有 \"下调至 \"表现不佳\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCK","PCOR","IE00BWXC8680.SGD","TW","BK4581","BRZE","LU2125909593.SGD","LU0965509010.AUD","DAY","LW","OKTA","BK4539","IE00B19Z3581.USD","LU1923622291.USD","LU0251142724.SGD","EQIX","BFH","IE00B19Z9Z06.USD","PBH","SN","IDYA","BDTX","CHD","LU0689626769.HKD","SG9999001440.SGD","SHAK","BK4084","LU2237438978.USD","BK4504","SBUX","BK4532","IE00BZ1G4Q59.USD","LU2125909916.SGD","LU2125154778.USD","LU2106854487.HKD","BK4183","CRWD","COST","LU0965509101.SGD","KVUE","CL","LU2125909759.SGD","IE00B894F039.SGD","PG","ZVRA","BHVN","LU2242646821.SGD","REPL"],"gpt_icon":1},{"id":"2469063115","title":"更新版 1-Zevra Therapeutics公司罕见遗传性疾病药物定价高达每月10.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469063115","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469063115?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:45","pubTimestamp":1727095503,"startTime":"0","endTime":"0","summary":"     路透9月23日 - Zevra Therapeutics公司在周一的电话会议上说，该公司用于治疗一种罕见致命遗传性疾病的  药物Miplyffa的批发价为每月4万至10.6万美元，具体取决于用量。该公司表示，根据其扩大准入计划，平均月价格为每月 85,000 美元。据 H.C. Wainwright 分析师估计，该药的平均净定价为每年 50 万至 60 万美元。Miplyffa与米格鲁司他联用，可用于治疗成人和2岁及以上儿童鼻咽癌相关的神经症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2469113033","title":"Zevra Therapeutics公司为遗传性疾病药物定价，每月高达10.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469113033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469113033?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:28","pubTimestamp":1727094520,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月23日 - Zevra Therapeutics公司在周一的电话会议上说，该公司用于治疗一种罕见致命遗传性疾病的药物Miplyffa的批发价为每月4万至10.6万美元，具体取决于用量。美国卫生监管机构周五批准了这种药物，使其成为首个获得批准的治疗 Neimann-Pick 病 C 型的药物--这是一种影响神经系统和其他器官的罕见遗传病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA","LENZ","BK4139"],"gpt_icon":0},{"id":"2469967100","title":"BUZZ-Zevra Therapeutics 的罕见遗传病疗法获美国 FDA 批准，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2469967100","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469967100?lang=zh_cn&edition=full","pubTime":"2024-09-21 01:32","pubTimestamp":1726853571,"startTime":"0","endTime":"0","summary":"    9月20日 - ** Zevra Therapeutics   股价上涨1.5%至8.14美元 ** 美国食品和药物管理局批准了  Zevra 治疗 C 型 Neimann-Pick 病的药物，这是第一种治疗这种罕见致命遗传病的药物。** 口服药物Miplyffa与米格鲁司他联合使用，已获准用于治疗2岁及以上患者与NPC相关的神经症状。** ZVRA 计划在 8 到 12 周内在美国上市该药物** H.C. Wainwright 分析师 Oren Livnat 预计，Miplyffa 在美国的最高销售额约为 2.5 亿美元。** 美国食品和药物管理局此前拒绝批准该药，并延长了审查时间** 包括本交易日的走势在内，该股今年累计上涨约 27","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2468624839","title":"更新版 1-美国食品和药物管理局批准泽弗拉公司治疗罕见遗传病的方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2468624839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468624839?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:26","pubTimestamp":1726842385,"startTime":"0","endTime":"0","summary":"     路透9月20日 - 美国食品和药物管理局周五表示，该机构批准了Zevra Therapeutics公司的  治疗罕见致命遗传性疾病的药物，使其成为首个获得批准的治疗该疾病的药物。该 公司多年来一直在努力 将这种药物推向市场， 此前美国卫生监管机构拒绝批准这种药物，并 延长了对该疗法的审查 。这种口服药物被命名为 Miplyffa，现已获准 用于治疗 Neimann-Pick 病 C 型--一种影响神经系统和其他器官的罕见遗传性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"2468772629","title":"美国食品和药物管理局批准了泽夫拉的遗传性疾病治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2468772629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468772629?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:10","pubTimestamp":1726841402,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月20日 - 美国食品和药物管理局周五表示，美国食品和药物管理局批准了Zevra Therapeutics公司的  药物用于治疗一种罕见的致命遗传性疾病，这是首个获得批准的治疗该疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"gpt_icon":0},{"id":"2468662514","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468662514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468662514?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839050,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价快速上涨5.99%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4007","BK4139","LENZ"],"gpt_icon":1},{"id":"2468772265","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468772265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468772265?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752667,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Zevra Therapeutics, Inc.股票出现异动，股价急速上涨5.24%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1021.42%、333.61%、70.43%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.，振幅分别为18.34%、11.37%、9.65%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ZVRA"],"gpt_icon":0},{"id":"2461917887","title":"Zevra Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461917887","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461917887?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:35","pubTimestamp":1724175328,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时35分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.08%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821013529ab5ea72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821013529ab5ea72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ZVRA","LENZ","BK4139"],"gpt_icon":0},{"id":"2460717793","title":"Zevra Therapeutics, Inc.2024财年第二财季实现净利润-19.93百万美元，同比减少292.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717793","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717793?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:04","pubTimestamp":1723997077,"startTime":"0","endTime":"0","summary":"8月19日，Zevra Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-19.93百万美元，同比减少292.32%；其中营业收入为4.45百万美元，同比减少47.46%，每股基本收益为-0.48美元。从资产负债表来看，Zevra Therapeutics, Inc.总负债1.12亿美元，其中短期债务596000.00美元，资产负债比为1.29，流动比率为2.00。机构评级：截至2024年8月19日，当前有5家机构对Zevra Therapeutics, Inc.目标价做出预测，其中目标均价为18.00美元，其中最低目标价为11.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004479f363ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004479f363ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA"],"gpt_icon":0},{"id":"2459157170","title":"Zevra Therapeutics, Inc.盘中异动 早盘股价大涨5.16%报7.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459157170","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459157170?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:45","pubTimestamp":1723643136,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时45分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.16%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421453797198b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421453797198b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA","BK4139","BK4007"],"gpt_icon":0},{"id":"2458559594","title":"Zevra Therapeutics, Inc.盘中异动 快速跳水7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458559594","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458559594?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:30","pubTimestamp":1723210224,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价大幅下挫7.17%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.86%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213024aefe258c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213024aefe258c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZVRA","LENZ","BK4007"],"gpt_icon":0},{"id":"2457775254","title":"Zevra Therapeutics, Inc.股价拉升29.05% 市值涨9884.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775254","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775254?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865219,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分，Zevra Therapeutics, Inc.股票出现异动，股价急速拉升29.05%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140199f10746b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140199f10746b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2457747270","title":"HC Wainwright &amp; Co.：维持Zevra Therapeutics(ZVRA.US)评级，由买入调整至买入评级, 目标价由15.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457747270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457747270?lang=zh_cn&edition=full","pubTime":"2024-08-05 18:40","pubTimestamp":1722854400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4007","BK4139","ZVRA"],"gpt_icon":0},{"id":"2457450744","title":"Zevra TherapeuticsInc.：H.C. Wainwright将目标价从15美元上调至18美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457450744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457450744?lang=zh_cn&edition=full","pubTime":"2024-08-05 18:02","pubTimestamp":1722852156,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"2456269820","title":"Zevra Therapeutics公司：Arimoclomol NDA的处方药用户费行动日期已分配至2024年9月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2456269820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456269820?lang=zh_cn&edition=full","pubTime":"2024-08-03 05:51","pubTimestamp":1722635511,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ZVRA","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2455613112","title":"Zevra Therapeutics, Inc.盘中异动 股价大涨13.73%报6.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455613112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455613112?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:31","pubTimestamp":1722432679,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时31分，Zevra Therapeutics, Inc.股票出现波动，股价急速上涨13.73%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213119957183d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213119957183d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ZVRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zevra.com","stockEarnings":[{"period":"1week","weight":0.0404},{"period":"1month","weight":0.0843},{"period":"3month","weight":0.4033},{"period":"6month","weight":0.8783},{"period":"1year","weight":0.9428},{"period":"ytd","weight":0.2962}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0413},{"period":"3month","weight":0.0648},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.3709},{"period":"ytd","weight":0.2299}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zevra Therapeutics, Inc.是一家从事专利新分子实体（NME）的前体药物的发现和开发临床阶段的专业制药公司。他们相信会有有所改善的广泛的处方，批准药品版本的发现和开发。他们最先进的候选产品，KP201 / APAP，包括KP201，它们的氢的前体药物，对乙酰氨基酚结合，或APAP的。他们正在开发KP201 / APAP作为立即释放，或IR，候选产品为短期，或超过14天不再，管理的急性疼痛。他们设计KP201 / APAP虐待威慑性，以解决在美国的阿片类药物滥用的流行。他们提交了一份新药申请，或NDA，根据第505（B）（2）联邦食品，药品和化妆品法，也称为505（B）（2）NDA，为KP201 / APAP美国食品药品监督管理局，FDA还是在2015年12月美国食品药物管理局随后接受了保密协议的优先审查二月2016年美国食品药物管理局已对处方药用户自由法案，或PDUFA，六月下设置了NDA进行审查的目标行动日期9，2016年他们还计划针对疼痛和注意力缺陷多动症寻找大的市场机会研发更多的前体药物的产品。 该公司成立于2006年10月30日，在爱荷华州注册成立，并在2014年5月30日于特拉华州重组。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.04085},{"month":2,"riseRate":0.555556,"avgChangeRate":0.053334},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.050529},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.035663},{"month":5,"riseRate":0.5,"avgChangeRate":-0.036976},{"month":6,"riseRate":0.689655,"avgChangeRate":0.030097},{"month":7,"riseRate":0.4,"avgChangeRate":-0.006106},{"month":8,"riseRate":0.6,"avgChangeRate":0.098178},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03249},{"month":10,"riseRate":0.4,"avgChangeRate":-0.097677},{"month":11,"riseRate":0.444444,"avgChangeRate":0.060314},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.029369}],"exchange":"NASDAQ","name":"Zevra Therapeutics","nameEN":"Zevra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zevra Therapeutics,ZVRA,Zevra Therapeutics股票,Zevra Therapeutics股票老虎,Zevra Therapeutics股票老虎国际,Zevra Therapeutics行情,Zevra Therapeutics股票行情,Zevra Therapeutics股价,Zevra Therapeutics股市,Zevra Therapeutics股票价格,Zevra Therapeutics股票交易,Zevra Therapeutics股票购买,Zevra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}